Singapore markets closed

Integer Holdings Corporation (ITGR)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
109.58-1.57 (-1.41%)
At close: 04:00PM EDT
109.58 -0.09 (-0.08%)
After hours: 04:11PM EDT

Integer Holdings Corporation

5830 Granite Parkway
Suite 1150
Plano, TX 75024
United States
214 618 5243
https://www.integer.net

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees10,500

Key executives

NameTitlePayExercisedYear born
Mr. Joseph W. DziedzicPresident, CEO & Director3.24M713.51k1968
Mr. Diron SmithExecutive VP & CFO651.22kN/A1974
Mr. McAlister C. Marshall IISenior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary854.89kN/A1970
Mr. Kirk K. ThorExecutive VP & Chief Human Resources Officer791.64kN/A1964
Mr. Payman KhalesPresident of Cardio & Vascular1.14MN/A1970
Mr. John HarrisExecutive Vice President of Global Operations & Manufacturing Strategy521.18k42.65k1960
Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting OfficerN/AN/A1971
Mr. Andrew SennSenior Vice President of Strategy, Business Development & Investor RelationsN/AN/A1982
Ms. Margaret CarthyExecutive VP of Global Quality & Regulatory AffairsN/AN/A1964
Mr. Jim StephensPresident of Cardiac Rhythm Management & NeuromodulationN/AN/A1974
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Corporate governance

Integer Holdings Corporation’s ISS governance QualityScore as of 1 April 2024 is 2. The pillar scores are Audit: 3; Board: 2; Shareholder rights: 2; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.